Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.

Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.

1980 • 300 citations

The role of WR-2721 in radiotherapy and/or chemotherapy.

1980 • 288 citations

Alkaline Phosphatase Promotes Radioprotection and Accumulation of WR-1065 in V79-171 Cells Incubated in Medium Containing WR-2721

1985 • 168 citations

Radioprotection of tumor and normal tissues by thiophosphate compounds

1973 • 136 citations

Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland

1984 • 133 citations

Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction

1994 • 111 citations

Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.

1981 • 105 citations

Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.

1974 • 82 citations

Pharmacokinetics of WR-2721

1988 • 78 citations

99mTc-pertechnetate uptake in parotid acinar cells by the Na+/K+/Cl- co-transport system.

1987 • 71 citations

Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine

1996 • 69 citations

Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.

1998 • 66 citations

Radioprotection by WR-2721 against Long-Term Chronic Damage to the Rat Parotid Gland

1978 • 64 citations

Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury

1986 • 62 citations

Specific protection of different normal tissues

1988 • 55 citations

Short-Term Radioprotective Effects of WR-2721 on the Rat Parotid Glands

1978 • 52 citations

Protection of normal tissues by WR2721 during fractionated irradiation

1976 • 49 citations

Biodistribution of the Radioprotective Drug 35 S-Labeled 3-Amino-2-Hydroxypropyl Phosphorothioate (WR77913)

1985 • 46 citations

Radioprotection by WR-2721 of gamma-irradiated rat parotid gland: Effect on gland weight and secretion at 8–10 days post irradiation

1984 • 43 citations

Value of quantitative salivary gland scintigraphy in the early stage of Sjörgenʼs syndrome

1995 • 41 citations

Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors

1986 • 35 citations

Protection of Normal Tissue against Late Radiation Injury by WR-2721

1981 • 35 citations

Synthesis, Biodistribution, and Autoradiography of Radiolabeled S-2-(3-Methylaminopropylamino)ethylphosphorothioic Acid (WR-3689)

1986 • 27 citations

[An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors].

1985 • 24 citations

Die quantitative Sialoszintigraphie -eine sinnvolle Untersuchung im Vorfeld und in der Nachsorge der Radiojodtherapie

1997 • 20 citations

Frequent Short-Term Oral Complications of Head and Neck Radiotherapy

1994 • 19 citations

Protection of salivary glands by amifostine in patients treated with high dose radioiodine

1997 • 5 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...